Reshaping the Fight against Heart Disease

Translate to Spanish or other 102 languages!

February is American Heart Month, a time for people to pay more attention to their cardiovascular health. Image for illustration purposes
February is American Heart Month, a time for people to pay more attention to their cardiovascular health. Image for illustration purposes

Mega Doctor News

- Advertisement -

By American Physiological Society (APS)

Rockville, Md. — February is American Heart Month, a time for people to pay more attention to their cardiovascular health. The American Physiological Society (APS) member-experts studying cardiovascular disease are advancing our understanding and underscoring the critical role of cardiovascular research happening behind the scenes. Physiologists, including APS member-experts, are studying several areas such as cardiovascular disease in women, how lack of sleep affects heart health, and cardiovascular health in premature babies. The research is aimed at developing new and improved treatments, as well as eliminating or reducing some heart disease risks.

Heart disease is the leading cause of death for men and women of all racial and ethnic backgrounds in the U.S., according to the U.S. Centers for Disease Control and Prevention (CDC). More than 650,000 people in the U.S. die each year from heart disease—about 1 in every 4 deaths, the CDC reports. The most common type of heart disease in the U.S. is coronary artery disease (CAD), the precursor to a heart attack. The annual cost of heart disease to the U.S. economy as of 2017 was $363 billion.  

- Advertisement -

There are many risk factors for heart disease, according to the CDC, including:

  • • Diabetes
  • • Obesity
  • • Physical inactivity
  • • Smoking
  • • Excessive alcohol use
  • • Unhealthy diet

APS has assembled a team of leading researchers to speak with science and health journalists about their cardiovascular research:

  • Andreas M. Beyer, PhD, FAHA, FCVS-APS, associate professor of medicine and physiology, co-director of cardio-oncology, Medical College of Wisconsin. His research focuses on microvascular function in patients with CAD or in cancer patients post-chemotherapy.
  • Licy L. Yanes Cardozo, MD, associate professor, University of Mississippi Medical Center. She studies cardiovascular disease in women, among other topics.
  • Jason R. Carter, PhD, professor, Montana State University. He is studying how lack of sleep from binge drinking affects heart health. Carter is a past Councilor of APS.
  • Melissa Bates, PhD, FAPS, assistant professor, University of Iowa. She conducts cardiovascular research in premature babies. Bates is chair of the APS Respiration Section.
  • Michael Sturek, MS, PhD, professor, Indiana University School of Medicine; adjunct professor, Purdue University, West Lafayette, Indiana; chair of the APS Cardiovascular Section. He studies CAD and other subjects.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recertified for Advanced Hip & Knee Replacements

DHR Health has once again earned The Joint Commission's Advanced Certification in Total Hip and Total Knee Replacement, reaffirming its commitment to providing high-quality, patient-centered orthopedic care to the Rio Grande Valley.

STHS Named to Newsweek’s America’s Greatest Midsize Workplaces for Women

The American workforce is more diverse than ever, with women helping lead that transformation. 

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

New Study Reveals Real-World Safety Findings for Latest Alzheimer’s Treatment

As new Alzheimer’s drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them, and whether they truly slow the disease outside tightly controlled studies.
- Advertisement -